vTv Therapeutics (VTVT) Operating Expenses (2014 - 2026)
vTv Therapeutics (VTVT) posted Operating Expenses of $13.6 million for Q1 2026, up 72.18% sequentially from $7.9 million in Q4 2025, and up 108.77% YoY from $6.5 million in Q1 2025.
vTv Therapeutics (VTVT) Operating Expenses (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported Operating Expenses for 13 years, with the latest figure at $13.6 million in Q1 2026.
- Quarterly Operating Expenses rose 108.77% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.9 million (up 59.06% YoY) and the FY2025 annual result came in at $32.8 million, up 30.21% from the prior year.
- Operating Expenses climbed to $13.6 million in Q1 2026 per VTVT's latest filing, from $7.9 million in the prior quarter.
- Over five years, Operating Expenses peaked at $13.6 million in Q1 2026 and troughed at $4.0 million in Q2 2022.
- A 5-year average of $7.2 million and a median of $6.6 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses tumbled 42.87% in 2022, then soared 108.77% in 2026.
- Over 5 years, Operating Expenses stood at $6.4 million in 2022, then fell by 25.9% to $4.7 million in 2023, then gained by 4.29% to $4.9 million in 2024, then soared by 60.62% to $7.9 million in 2025, then jumped by 72.18% to $13.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $13.6 million, $7.9 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | 13.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.93 Mn |
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 7.89 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 4.91 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | 7.16 Mn |
| Mar 31, 2024 | 6.63 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 5.37 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Mar 31, 2023 | 7.43 Mn |
| Dec 31, 2022 | 6.35 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 8.48 Mn |
| Dec 31, 2021 | 11.12 Mn |
| Sep 30, 2021 | 4.60 Mn |